|
1
|
Markowski J, Sieroń AL, Kasperczyk K,
Ciupińskakajor M, Auguściakduma A and Likus W: Expression of the
tumor suppressor gene hypermethylated in cancer 1 in laryngeal
carcinoma. Oncol Lett. 9:2299–2302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pei SG, Wang JX, Wang XL, Zhang QJ and
Zhang H: Correlation of survivin, p53 and Ki-67 in laryngeal cancer
Hep-2 cell proliferation and invasion. Asian Pac J Trop Med.
8:636–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang X, An L and Li X: Arsenic trioxide
induced endoplasmic reticulum stress in laryngeal squamous cell
line Hep-2 cells. Auris Nasus Larynx. 41:81–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng JZ, Yu D, Zhang H, Jin CS, Liu Y,
Zhao X, Qi XM and Liu XB: Inhibitive effect of IL-24 gene on
CD133(+) laryngeal cancer cells. Asian Pac J Trop Med. 7:867–872.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Min JW, Kim KI, Kim HA, Kim EK, Noh WC,
Jeon HB, Cho DH, Oh JS, Park IC, Hwang SG and Kim JS:
INPP4B-mediated tumor resistance is associated with modulation of
glucose metabolism via hexokinase 2 regulation in laryngeal cancer
cells. Biochem Biophys Res Commun. 440:137–142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kang R, Wang ZH, Wang BQ, Zhang CM, Gao W,
Feng Y, Bai T, Zhang HL, Huang-Pu H and Wen SX: Inhibition of
autophagy-potentiated chemosensitivity to cisplatin in laryngeal
cancer Hep-2 cells. Am J Otolaryngol. 33:678–684. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang D and Wu X: In vitro and in vivo
targeting of bladder carcinoma with metformin in combination with
cisplatin. Oncol Lett. 10:975–981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cimbora-Zovko T, Fritz G, Mikac N and
Osmak M: Downregulation of RhoB GTPase confers resistance to
cisplatin in human laryngeal carcinoma cells. Cancer Lett.
295:182–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu T, Peng H, Zhang M, Deng Y and Wu Z:
Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling
pathway, enhances the chemosensitivity of laryngeal squamous cell
carcinoma cells to cisplatin. Eur J Pharmacol. 641:15–22. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong-Jun XU, Meng Y and Sun YX: Effects of
ginsenoside Rh_2 associated with cisplatin on human laryngeal
squamous cell carcinoma strain Hep-2. Chin J Lab Diagn. 10:506–508.
2005.
|
|
11
|
Ahlskog JK, Dumelin CE, Trüssel S, Mårlind
J and Neri D: In vivo targeting of tumor-associated carbonic
anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett.
19:4851–4856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cazzamalli S, Corso AD and Neri D: Linker
stability influences the anti-tumor activity of acetazolamide-drug
conjugates for the therapy of renal cell carcinoma. J Control
Release. 246:39–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan G and Dong Z: Effect of inhibiting
aquaporin-1 on proliferation and apoptosis of the Hep-2 cell. Lin
Chuang Er Bi Yan Hou Ke Za Zhi. 20:988–991. 2006.(In Chinese).
PubMed/NCBI
|
|
14
|
Zhang X, Zhang L and Zou Y: Research
evolution of cisplatin antitumor drugs and cisplatin-loaded. China
Mod Med. 18:25–27. 2011.
|
|
15
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan S, Ping W, Yin W and Wei Z:
Enhancement effect of resveratrol on sensitivity of laryngeal
carcinoma Hep-2 cells to cisplatin and its mechanism. J Jilin Uni.
41:282–286. 2015.
|
|
17
|
Cui Y, Chao W, Xu D, Meng W and Quan X:
AstragalosideII inhibits autophagic flux and enhance
chemosensitivity of cisplatin in human cancer cells. Biomed
Pharmacother. 81:166–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh M, Bhui K, Singh R and Shukla Y: Tea
polyphenols enhance cisplatin chemosensitivity in cervical cancer
cells via induction of apoptosis. Life Sci. 93:7–16. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao ZH, Lin W and Hai W: Recent progress
in clinical application of the carbonic anhydrase inhibitor,
acetazolamide. Chin J New Drugs. 17:1390–1394. 2008.
|
|
20
|
Kong B, Xiao-Hua WU and Yong LI: Effects
of aquaporin protein inhibitor acetazolamide on xenograft tumor
growth of colon cancer in nude mice. China J Modern Med.
20:1466–1465. 2010.
|
|
21
|
Bin K and Shi-Peng Z: Acetazolamide
inhibits aquaporin-1 expression and colon cancer xenograft tumor
growth. Hepatogastroenterology. 58:1502–1506. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nör C, Zhang Z, Warner KA, Bernardi L,
Visioli F, Helman JI, Roesler R and Nör JE: Cisplatin induces Bmi-1
and enhances the stem cell fraction in head and neck Cancer.
Neoplasia. 16:137–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu YY, Wu TT, Zhou SH, Bao YY, Wang QY,
Fan J and Huang YP: Apigenin suppresses GLUT-1 and p-AKT expression
to enhance the chemosensitivity to cisplatin of laryngeal carcinoma
Hep-2 cells: An in vitro study. Int J Clin Exp Pathol. 7:3938–3947.
2014.PubMed/NCBI
|
|
24
|
Ju SM, Kang JG, Bae JS, Pae HO, Lyu YS and
Jeon BH: The flavonoid apigenin ameliorates cisplatin-induced
nephrotoxicity through reduction of p53 activation and promotion of
PI3K/Akt pathway in human renal proximal tubular epithelial cells.
Evid Based Complement Alternat Med. 2015:1864362015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao W, Ying L, Qin R, Liu D and Feng Q:
Silence of fibronectin 1 increases cisplatin sensitivity of
non-small cell lung cancer cell line. Biochem Biophys Res Commun.
476:35–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamauchi K, Sakurai H, Kimura T,
Wiriyasermkul P, Nagamori S, Kanai Y and Kohno N: System L amino
acid transporter inhibitor enhances anti-tumor activity of
cisplatin in a head and neck squamous cell carcinoma cell line.
Cancer Lett. 276:95–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang XK, Zheng F, Chen JH, Gao QL, Lu YP,
Wang SX, Wang CY and Ma D: Relationship between expression of
apoptosis-associated proteins and caspase-3 activity in
cisplatin-resistant human ovarian cancer cell line. Ai Zheng.
21:1288–1291. 2002.(In Chinese). PubMed/NCBI
|
|
28
|
Shi-Hong MA and Tan WH: Expression and
clinical significance of FHIT and PCAN protein in endometrial
carcinoma. J Harbin Med Uni. 43:62–65. 2009.
|
|
29
|
Sittel C, Ruiz S, Volling P, Kvasnicka HM,
Jungehülsing M and Eckel HE: Prognostic significance of Ki-67
(MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Oral Oncol. 35:583–589. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo GQ, Dai D and Dong-Mei WU: The
clinical implication of experession for both PCNA and p53 protein
in larynx cancer patients. Ningxia Med J. 2001.
|
|
31
|
Wang ZM, Chang-Shao XU and Sun YM: The
clinic value of the expression of p53, p16, PCNA protein in
esophageal carcinoma. Bull Chin Cancer. 15:61–62. 2006.
|
|
32
|
Zeng R: Expression of p53, p21, PCNA and
COX-2 and its relationship with recurrence in the early-stage
laryngeal cancer with negative surgical margin. Lin Chung Er Bi Yan
Hou Tou Jing Wai Ke Za Zhi. 30:349–352. 2016.(In Chinese).
PubMed/NCBI
|
|
33
|
Pfister NT, Yoh KE and Prives C: p53, DNA
damage, and NAD+ homeostasis. Cell Cycle. 13:1661–1662. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hayashi Y, Edwards NA, Proescholdt MA,
Oldfield EH and Merrill MJ: Regulation and function of aquaporin-1
in glioma cells. Neoplasia. 9:777–787. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guan B, Sun L and Dong Z: The expression
and distribution of Aquaporin 1 and Aquaporin 4 in laryngeal
carcinoma and its significance. Chin J Clin Oncol. 21:269–272.
2005.
|
|
36
|
Musumeci G, Leonardi R, Carnazza ML,
Cardile V, Pichler K, Weinberg AM and Loreto C: Aquaporin 1 (AQP1)
expression in experimentally induced osteoarthritic knee menisci:
An in vivo and in vitro study. Tissue Cell. 45:145–152. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hoque MO, Soria JC, Woo J, Lee T, Lee J,
Jang SJ, Upadhyay S, Trink B, Monitto C, Desmaze C, et al:
Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3
cell proliferation and anchorage-independent growth. Am J Pathol.
168:1345–1353. 2006. View Article : Google Scholar : PubMed/NCBI
|
